<DOC>
	<DOC>NCT00981123</DOC>
	<brief_summary>Observational, non-comparative, epidemiological study to collect and analyse real life data on schizophrenic patients receiving quetiapine according to the standard medical practice in Croatia. The main objectives are to assess after 6 months of quetiapine therapy severity of illness and global improvement in patients using Clinical Global Impression (CGI) scale.</brief_summary>
	<brief_title>Non-interventional (NI) Study to Observe Efficacy and Usage of Quetiapine in Acute Episodes of Schizophrenia and as Maintenance Therapy Following Standard Clinical Practice in Croatia</brief_title>
	<detailed_description />
	<mesh_term>Schizophrenia</mesh_term>
	<mesh_term>Quetiapine Fumarate</mesh_term>
	<criteria>Patients with diagnosis of schizophrenia Patients who are already treated with quetiapine for at least 12 weeks (outpatients or hospitalised patients) Patients capable of signing ICF Patients with hypersensitivity to active substance or any of the excipients of this product Patients with contraindication for quetiapine therapy according to the approved SmPC</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2011</verification_date>
</DOC>